XRX trades 239.4% below Wall Street's consensus target of $10.25.
Last 12 months price action with 12-month analyst target path
The base valuation assumes XRX achieves its forward estimates and maintains a stable P/E multiple of historical averagesx. This scenario reflects the blended consensus of 5 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 22, 2026, Xerox Holdings Corporation (XRX) has a Wall Street consensus price target of $10.25, based on estimates from 5 covering analysts. With the stock currently trading at $3.02, this represents a potential upside of +239.4%. The company has a market capitalization of $395M.
Analyst price targets range from a low of $8.00 to a high of $14.00, representing a 59% spread in expectations. The median target of $9.50 differs from the mean, suggesting potential outlier estimates. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Sell, with 0 analysts rating the stock as a Buy or Strong Buy,2 rating it Hold, and 3 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, XRX trades at a trailing P/E of -0.4x. Analysts expect EPS to grow +97.1% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
HPQHP Inc. | $21.5B | $23.50 | $19.83 | -15.6% | Hold | 7.8x | 52 |
MSFTMicrosoft Corporation | $2.8T | $379.40 | $551.96 | +45.5% | Buy | 22.6x | 82 |
ORCLOracle Corporation | $530.1B | $184.31 | $253.50 | +37.5% | Buy | 22.9x | 86 |
NTAPNetApp, Inc. | $31.6B | $159.71 | $167.00 | +4.6% | Hold | 20.0x | 71 |
NTNXNutanix, Inc. | $12.7B | $46.90 | $56.67 | +20.8% | Buy | 24.5x | 32 |
CSCOCisco Systems, Inc. | $471.2B | $119.54 | $123.30 | +3.1% | Buy | 28.0x | 73 |
PSTGEverpure, Inc | $28.5B | $86.22 | $86.00 | -0.3% | Buy | 37.6x | 32 |
OPENOpendoor Technologies Inc. | $3.4B | $4.47 | $6.17 | +38.0% | Hold | — | 26 |
DOCUDocuSign, Inc. | $8.3B | $43.47 | $58.71 | +35.1% | Hold | 11.5x | 28 |
UPLDUpland Software, Inc. | $15M | $5.19 | — | — | — | — | — |
Quick answers to the most common questions about buying XRX stock.
The consensus Wall Street price target for XRX is $10.25, representing 239.4% upside from the current price of $3.02. With 5 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
XRX has a consensus rating of "Sell" based on 5 Wall Street analysts. The rating breakdown is leaning bearish, with 3 Sell/Strong Sell ratings. The consensus 12-month price target of $10.25 implies 239.4% upside from current levels.
XRX's current price is $3.02 with a consensus target of $10.25 (239.4% implied move). Analyst estimates suggest the stock is undervalued at current levels.
The most bullish Wall Street analyst has a price target of $14 for XRX, while the most conservative target is $8. The consensus of $10.25 represents the median expectation. These targets typically reflect 12-month expectations.
XRX is moderately covered, with 5 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 0 have Buy ratings, 2 recommend Hold, and 3 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month XRX stock forecast based on 5 Wall Street analysts shows a consensus price target of $10.25, with estimates ranging from $8 (bear case) to $14 (bull case). The median consensus rating is "Sell".
Wall Street analysts are very optimistic on XRX, with a "Sell" consensus rating and $10.25 price target (239.4% upside). 0 of 5 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
XRX analyst price targets range from $8 to $14, a 59% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $10.25 consensus represents the middle ground.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.